Genetic aberrations affecting exon 3 of CTNNB1 in the form of deletions or missense mutations that make beta-catenin stable and constitutively active were found to occur in HB at a rate of nearly 48% [19]. This evidence concerns the gene CTNNB1 and hemoglobin measurement.